Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration
Crossref DOI link: https://doi.org/10.1208/s12249-017-0804-3
Published Online: 2017-05-22
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Czarnobaj, Katarzyna
Prokopowicz, Magdalena
Sawicki, Wiesław
License valid from 2017-05-22